These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


554 related items for PubMed ID: 27852010

  • 41. Mixed urinary symptoms: what are the urodynamic findings?
    Digesu GA, Salvatore S, Fernando R, Khullar V.
    Neurourol Urodyn; 2008; 27(5):372-5. PubMed ID: 17943988
    [Abstract] [Full Text] [Related]

  • 42. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD, Liao CH, Chen YC, Kuo HC.
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The long term predictive value of preoperative pressure flow studies in the resolution of overactive bladder after insertion of a retropubic midurethral sling.
    Duckett J, Balachandran A.
    Neurourol Urodyn; 2017 Nov; 36(8):2074-2077. PubMed ID: 28220609
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Evaluation of bladder capacity in children with lower urinary tract symptoms: Comparison of 48-hour frequency/volume charts and uroflowmetry measurements.
    Maternik M, Chudzik I, Krzeminska K, Żurowska A.
    J Pediatr Urol; 2016 Aug; 12(4):214.e1-5. PubMed ID: 27329866
    [Abstract] [Full Text] [Related]

  • 48. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
    Ackerman AL, Lai HH, Parameshwar PS, Eilber KS, Anger JT.
    BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
    [Abstract] [Full Text] [Related]

  • 49. Correlation between urinary symptoms and urodynamic findings: Is the bladder an unreliable witness?
    D'Alessandro G, Palmieri S, Cola A, Barba M, Manodoro S, Frigerio M.
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():130-133. PubMed ID: 35305346
    [Abstract] [Full Text] [Related]

  • 50. Overactive bladder in Taiwanese women: re-analysis of epidemiological database of community from 1999 to 2001.
    Chen YC, Ng SC, Chen SL, Huang YH, Hu SW, Chen GD.
    Neurourol Urodyn; 2012 Jan; 31(1):56-9. PubMed ID: 21826728
    [Abstract] [Full Text] [Related]

  • 51. Ultrasound assessment of bladder wall thickness as a screening test for detrusor instability.
    Abou-Gamrah A, Fawzy M, Sammour H, Tadros S.
    Arch Gynecol Obstet; 2014 May; 289(5):1023-8. PubMed ID: 24276424
    [Abstract] [Full Text] [Related]

  • 52. Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity.
    Serati M, Campitiello MR, Torella M, Mesiano G, Scancarello C, Ghezzi F, Papadia A, Gamarra E, Caccia G, Braga A.
    J Clin Med; 2024 Sep 28; 13(19):. PubMed ID: 39407869
    [Abstract] [Full Text] [Related]

  • 53. Voiding efficiency in children is significantly impaired by the presence of the urethral catheter during pressure-flow studies.
    Fugaru I, Di Re L, Edvi M, Campeau L, El-Sherbiny M, Capolicchio JP.
    J Pediatr Urol; 2023 Oct 28; 19(5):541.e1-541.e7. PubMed ID: 37550095
    [Abstract] [Full Text] [Related]

  • 54. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms.
    Abdel-Fattah M, Chapple C, Guerrero K, Dixon S, Cotterill N, Ward K, Hashim H, Monga A, Brown K, Drake MJ, Gammie A, Mostafa A, Bladder Health UK, Breeman S, Cooper D, MacLennan G, Norrie J.
    Trials; 2021 Oct 26; 22(1):745. PubMed ID: 34702331
    [Abstract] [Full Text] [Related]

  • 55. Childhood enuresis is a risk factor for bladder dysfunction in adult life?
    D'Ancona CA, Lopes MH, Faleiros-Martins AC, Lúcio AC, Campos RM, Costa JV.
    Neurourol Urodyn; 2012 Jun 26; 31(5):634-6. PubMed ID: 22461203
    [Abstract] [Full Text] [Related]

  • 56. Epidemiology and impact of urinary incontinence, overactive bladder, and other lower urinary tract symptoms: results of the EPIC survey in Russia, Czech Republic, and Turkey.
    Kogan MI, Zachoval R, Ozyurt C, Schäfer T, Christensen N.
    Curr Med Res Opin; 2014 Oct 26; 30(10):2119-30. PubMed ID: 24932562
    [Abstract] [Full Text] [Related]

  • 57. Overactive bladder symptoms: do we need urodynamics?
    Digesu GA, Khullar V, Cardozo L, Salvatore S.
    Neurourol Urodyn; 2003 Oct 26; 22(2):105-8. PubMed ID: 12579626
    [Abstract] [Full Text] [Related]

  • 58. Reliability of urodynamic interpretation in women presenting with urinary incontinence at a tertiary hospital.
    Mohsin Rizvi R, Chughtai NG.
    Urol Int; 2012 Oct 26; 88(4):410-4. PubMed ID: 22156382
    [Abstract] [Full Text] [Related]

  • 59. [Effect of the type of urinary incontinence on the quality of life of patients in the public healthcare system in Southeastern Brazil].
    Faria CA, Moraes JR, Monnerat BR, Verediano KA, Hawerroth PA, Fonseca SC.
    Rev Bras Ginecol Obstet; 2015 Aug 26; 37(8):374-80. PubMed ID: 26312393
    [Abstract] [Full Text] [Related]

  • 60. The role of serum C-reactive protein in women with lower urinary tract symptoms.
    Hsiao SM, Lin HH, Kuo HC.
    Int Urogynecol J; 2012 Jul 26; 23(7):935-40. PubMed ID: 22422219
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.